Axogen
AXGN
P/S ratio for Axogen (AXGN)
P/S ratio as of May 2024 (TTM): 1.59
According to Axogen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.59138. At the end of 2023 the company had a P/S ratio of 1.85.
P/S ratio history for Axogen from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.85 | -39.29% |
| 2022 | 3.05 | -0.41% |
| 2021 | 3.06 | -52.77% |
| 2020 | 6.47 | -2.45% |
| 2019 | 6.64 | -29.9% |
| 2018 | 9.47 | -40.99% |
| 2017 | 16.0 | 122.78% |
| 2016 | 7.20 | 31.3% |
| 2015 | 5.49 | 31.85% |
| 2014 | 4.16 | -41.5% |
| 2013 | 7.11 | 82.15% |
| 2012 | 3.90 | -35.96% |
| 2011 | 6.10 | -64.88% |
| 2010 | 17.4 | 2407.11% |
| 2009 | 0.6923 | -99.57% |
| 2008 | 162 | |
| 2006 | 7.08 | 48.38% |
| 2005 | 4.77 | 519.01% |
| 2004 | 0.7710 | 73.11% |
| 2003 | 0.4454 | 50.87% |
| 2002 | 0.2952 | -37.97% |
| 2001 | 0.4759 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 3.36 | 111.07% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 5.11 | 221.01% | 🇺🇸 USA |
 Boston Scientific BSX | 7.28 | 357.62% | 🇺🇸 USA |